Mammography is one of the most commercially concentrated segments in diagnostic imaging — Hologic holds approximately 60% of the global installed base in digital breast tomosynthesis systems. The market is growing steadily as organized breast cancer screening programs expand globally, 3D tomosynthesis continues to replace conventional 2D mammography, and AI-powered reading assistance is adopted to address radiologist shortages and improve screening sensitivity. GE HealthCare, Siemens Healthineers, and Fujifilm are the primary competitors to Hologic.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Mammography Market Size and Growth
• Digital Breast Tomosynthesis
• Hologic Market Leadership
• AI in Mammography Screening
• Contrast-Enhanced Mammography
• Breast MRI
• Competitive Landscape
Table of Contents
1. Executive Summary
2. Market Overview
3. Mammography Market Size and Growth
4. Digital Breast Tomosynthesis
5. Hologic Market Leadership
6. AI in Mammography Screening
7. Contrast-Enhanced Mammography
8. Breast MRI
9. Competitive Landscape
10. Regional Market Analysis
11. Strategic Conclusions
12. Appendix
List of Tables
Table 1. Market Size and Growth 2025
Table 2. Segment Breakdown 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Market Share 2025
Table 4. M&A and Innovation Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Canon Medical
Fujifilm Healthcare
GE HealthCare
Hologic
iCAD
Philips
Siemens Healthineers
Volpara Health
